Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro

Journal of Clinical Investigation

Volumn 97, Issue 11, 1996, Pages 2534-2540

  Slatopolsky, Eduardo ^a   Finch, Jane ^a   Denda, Masashi ^a   Ritter, Cindy ^a   Zhong, Min ^a   Dusso, Adriana ^a   MacDonald, Paul N ^b   Brown, Alex J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calcitriol; Calcium; Hyperparathyroidism; Phosphorus; Uremia

Indexed keywords

CALCITRIOL; CALCIUM ION; CYCLOHEXIMIDE; MESSENGER RNA; PARATHYROID HORMONE; PHOSPHORUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATTLE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DIET RESTRICTION; FEMALE; NONHUMAN; ORGAN CULTURE; ORGAN WEIGHT; PARATHYROID CELL; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HORMONE RELEASE; PARATHYROID HYPERPLASIA; PATHOGENESIS; PRIORITY JOURNAL; RAT; UREMIA;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD UREA NITROGEN; CALCIUM; CATTLE; CELLS, CULTURED; CREATININE; FEMALE; HUMANS; HYPERPLASIA; NEPHRECTOMY; ORGAN SIZE; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHORUS; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REGRESSION ANALYSIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UREMIA;

EID: 0029887094     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118701     Document Type: Article

References (29)

1. 3 by phosphorus in normal men. J. Clin. Invest. 83:1494-1499.
2. Portale, A.A., B.E. Booth, B.P. Halloran, and R.C. Morris. Jr. 1984. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxy-vitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency. J. Clin. Invest. 73:1580-1589.
3. Lucas, P.A., R.C. Brown, J.S. Woodhead, and G.A. Coles. 1986. 1,25-dihydroxycholecalciferol and parathyroid hormone in advanced chronic renal failure: effect of simultaneous protein and phosphorus restriction. Clin. Nephrol. 25:7-10.
4. Schaefer, K., C.M. Erley, D. von Herrath, and G. Stein. 1989. Calcium salts of ketoacids as a new treatment strategy for uremic hyperphosphatemia. Kidney Int. 36:S136-S139.
5. Aparicio, M., C. Combe, M.H. Lafage, V. De Precigout, L. Potaux, and J.L. Bourchet. 1994. In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of the levels of calcitriol. Nephron. 63:122-123.
6. Lopez-Hilker, S., A. Dusso, N. Rapp, K.J. Martin, and E. Slatopolsky. 1990. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol. Am J. Physiol. 259:F432-F437.
7. MacGregor, R.R., M.P. Sarras, A. Houle, and D.V. Cohn. 1983. Primary monolayer cell culture of bovine parathyroids: effects of calcium, isoproterenol and growth factors. Mol. Cell. Endocrinol. 30:313-328.
8. LePecq, J.B., and C. Paoletti. 1966. A new fluorometric method for RNA and DNA determination. Anal. Biochem. 17:100-107.
9. Hruska, K.A., R. Kopelman, W.E. Rutherford, S. Klahr, and E. Slatopolsky. 1975. Metabolism of immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J. Clin. Invest. 56:39-48.
10. MacDonald, P.N., C. Ritter, A. Brown, and E. Slatopolsky. 1994. Retinoic acid suppresses PTH secretion and pre-pro PTH mRNA levels in bovine parathyroid cell culture. J. Clin. Invest. 93:725-730.
11. 3 involving a novel single extraction and purification procedure. Clin. Chem. 32:2020-2023.
12. Reinhardt, T.A., R.L. Horst, V. Orf, and B.W. Hollis. 1984. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J. Clin. Endocrinol. & Metab. 58:91-98.
13. Drake, T.G., F. Albright, and B. Castleman. 1937. Parathyroid hyperplasia in rabbits produced by parenteral phosphate administration. J. Clin. Invest. 16:203-206.
14. Slatopolsky, E., S. Caglar, J.P. Pennell, D.D. Taggart, J. M. Canterbury, E. Reiss, and N. S. Bricker. 1971. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J. Clin. Invest. 50:492-499.
15. Slatopolsky, E., W.E. Rutherford, P.E. Hoffsten, I.O. Elkan, H.R. Butcher, and N. S. Bricker. 1972. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease. Kidney Int. 1:43-51.
16. Slatopolsky, E., S. Caglar, L. Gradowska, J. Canterbury, E. Reiss, and N.S. Bricker. 1972. On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using "proportional reduction" of dietary phosphorus intake. Kidney Int. 2:147-151.
17. Slatopolsky, E., and N.S. Bricker. 1973. The role of phosphate restriction in the prevention of secondary hyperparathyroidism in chronic renal disease. Kidney Int. 4:141-149.
18. Rutherford, W.E., P. Bordier, P. Marie, K. Hruska, H. Harter, A. Greenwalt, J. Blondin, J. Haddad, N. Bricker, and E. Slatopolsky. 1977. Phosphate control and 25-hydroxy-cholecalciferol administration in preventing experimental renal osteodystrophy in the dog. J. Clin. Invest. 60:332-341.
19. Reiss, E., M.J. Canterbury, and M.A. Bercovitz. 1970. The role of phosphate in the secretion of parathyroid hormone in man. J. Clin. Invest. 49:2146-2149.
20. Kilav, R., J. Silver, and T. Naveh-Many. 1995. Parathyroid hormone gene expression in hypophosphatemic rats. J. Clin. Invest. 96:327-333.
21. Yi, H., M. Fukagawa, H. Yamato, M. Kumagai, T. Watanabe, and K. Kurokawa. 1995. Prevention of enhanced parathyroid hormone secretion, synthesis and hyperplasia by mild dietary phosphorus restriction in early chronic renal failure in rats: possible direct role of phosphorus. Nephron. 70:242-248.
22. Naveh-Many, T., R. Rahamimo, N. Livni, and J. Silver. 1995. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate and vitamin D. J. Clin. Invest. 96:1786-1793.
23. Quarles, L.D., D.A. Yaohay, B.A. Carroll, C.E. Spritzer, S.A. Minda, D. Bartalomay, and B. deBaugh. 1994. Prospective trial pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int. 45: 1710-1721.
24. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J. Clin. Invest. 92:1436-1443.
25. Arnold, A., M. F. Brown, P. Urena, R. Gaz, E. Sarfati, and T. Drücke. 1995. Monoclonality of parathyroid tumors in chronic renal failure and primary parathyroid hyperplasia. J. Clin. Invest. 95:2047-2053.
26. Denda, M., J. Finch, and E. Slatopolsky. 1995. Parathyroid hyperplasia and secondary hyperparathyroidism develop rapidly in experimental uremic rats. J. Bone Miner. Res. 10:S276.
27. Arnold, A., H.G. Kim, R.D. Gaza, R.L. Eddy, Y. Fukushima, M.G. Byers, T.B. Shows, and H.M. Kronenberg. 1989. Molecular cloning and chromosome mapping of DNA rearranged with the parathyroid hormone gene in parathyroid adenoma. J. Clin. Invest. 83:2034-2040.
28. Motokura, T., T. Bloom, T.B. Kim, H. Juppner, J.V. Ruderman, H.M. Kronenberg, and A. Arnold. 1991. A novel cyclin encoded by a bell - candidate oncogene. Nature (Lond.). 350:512-515.
29. Rosenberg, C., H.G. Kim, T.B. Shows, H.M. Kronenberg, and A. Arnold. 1991. Rearrangement and over-expression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene. 6:449-453.